Searchable abstracts of presentations at key conferences on calcified tissues

ba0005cabs.oc2.1 | Oral Communications | ECTS2016

Prostate cancer microRNAs in extracellular vesicles stimulate osteoclastogenesis

Bijnsdorp Irene , Mulder Jorn , Geldof Albert , Bakker Astrid , de Vries Teun , van Moorselaar Jeroen

Prostate cancer (PCa) is the most common cancer in males. When patients develop metastasis, no curative therapy is available. To find new therapeutic options, it is crucial to understand how PCa cells induce metastasis. Recently, it was shown that PCa cells secrete small extracellular vesicles (EVs) that can be found in the circulation and in bones. Uptake of EVs by other cells may change their behaviour. We previously identified three miRNAs that were uniquely upregulated in ...

ba0001cu2.3 | Clinical Update 2 | ECTS2013

Osteoporosis in SLE

Bultink Irene

Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disease that usually affects women during the childbearing ages. The disease can affect any organ system and varies in its clinical manifestations and severity between individuals. The disease course is characterized by relapses and remissions.Because survival of SLE patients has improved dramatically over the last decades, attention is now more focused on complications of the disease...

ba0006lb20 | (1) | ICCBH2017

COL2A1 c.1609G>A (p.Gly537Ser) a pathogenic variant causing multiple skeletal abnormalities and severe short stature

Vlachopapadopoulou Elpis , Dikaiakou Irene , Manolakos Emmanouil , Panagiotopoulos Ioannis , Michalacos Stefanos

Background: Skeletal dysplasias include many pathological conditions that involve bone metabolism and health and most of them are associated with short stature. 211 genes are associated with bone dysplasia and short stature. Presenting problem: To present a boy with severe short stature and skeletal abnormalities. He was born at term AGA. Growth failure was noted from the age of 8 months. IGF-I levels were low and he was tested for growth hormone deficie...

ba0003pp98 | Cancer and bone: basic, translational and clinical | ECTS2014

Biological markers of aggressive giant cell tumour of bone: an immunohistochemical study

Quattrini Irene , Pazzaglia Laura , Conti Amalia , Novello Chiara , Ferrari Cristina , Benassi Maria Serena

Giant cell tumour of bone (GCTb) is an osteolytic neoplasia with tendency to local recurrence (10–25%), while metastases or malignant transformation are described in 1–4% of cases.It is composed by three distinct populations that cross-talk each other generating unbalance in bone remodeling and activation of NF-kB signaling pathway.To identify new candidate biological markers useful for improving clinical management of GC...

ba0003pp220 | Osteoporosis: evaluation and imaging | ECTS2014

The fracture outpatient clinic: what is the additional value of vertebral assessments and which individuals should be more actively recruited?

Muilwijk Carolien , Lips Paul , Lems Willem , Bultink Irene , den Heijer Martin , de Jongh Renate

Fracture outpatient (FO) clinics aim to identify individuals at high fracture risk. Identification of individuals at high fracture risk has been improved since the introduction of vertebral fracture assessment (VFA). Unfortunately, participation rates in FO clinics are often low.The aim of this study is to i) assess the contributory value of VFA in addition to BMD measurements in identifying individuals with high fracture risk; ii) assess characteristics...

ba0003pp290 | Osteoporosis: pathophysiology and epidemiology | ECTS2014

Novel evidence that apolipoprotein A-I deficiency is implicated in the pathogenesis of osteoporosis in mice

Kalyvioti Eleni , Kypreos Kyriakos , Papachristou Nicholas , Orkoula Malvina , Triantaphyllidou Irene-Eva , Blair Harry , Papachristou Dionysios

Introduction: Recent data suggest that lipid metabolism imbalances affect osteoblast and osteoclast function resulting in altered bone mass quality and quantity. Here we investigated the role of apolipoprotein A-I (apoA-I), key-element in HDL biogenesis in the pathogenesis of osteoporosis in mice.Materials and methods: Lumbar vertebrae and femora from apoA-I deficient (ApoA-I−/−) and WT (ApoA-I<s...

ba0003pp291 | Osteoporosis: pathophysiology and epidemiology | ECTS2014

Apolipoprotein-E deficiency predisposes to the development of osteoporosis following long-term exposure to western-type diet, in mice

Papachristou Nicholas , Kalyvioti Eleni , Triantaphyllidou Irene-Eva , Blair Harry , Kypreos Kyriakos , Papachristou Dionysios

Introduction: Recent data suggest that lipid metabolism imbalances affect bone cell function and therefore may result in the development of osteoporosis. We investigated the role of apolipoprotein-E (ApoE), a plasma protein playing cardinal role in lipoprotein metabolism, in the regulation of osteoblast and osteoclast function and the pathogenesis of osteoporosis.Material and methods: We used apoE deficient (ApoE−/−) and C57BL/6 (c...

ba0005p9 | Arthritis and other joint diseases: translational and clinical | ECTS2016

Apolipoprotein E aggravates inflammation and bone destruction in murine antigen – induced arthritis

Ascone Giuliana , Ceglie Irene Di , de Munter Wouter , Walgreen Birgitte , Sloetjes Annet , van Lent Peter

Background and Objectives: Rheumatoid arthritis (RA) is a chronic disease characterized by severe bone destruction which has been associated with altered lipid metabolism. Apolipoprotein E (Apo E) is a lipoprotein mainly produced by macrophages. ApoE has been described as crucial in lipid metabolism but also as an important anti-inflammatory mediator regulating innate immunity and bone turnover. In the present study we investigated the role of Apo E in bone destruction during ...